Boston Scientific faces reimbursement hurdles for lung-searing asthma … – FierceMedicalDevices (press release) (registration)

Boston Scientific faces reimbursement hurdles for lung-searing asthma
FierceMedicalDevices (press release) (registration)
Boston Scientific ($BSX) had high hopes for its electrode-tipped catheter treatment for asthma after snatching up the system in 2010 through its $193.5 million purchase of Asthmatx. But the company is hitting a wall with the product as insurers

and more »

View full post on asthma – Google News

Aerocrine: Positive reimbursement coverage continues for Aerocrine’s asthma test – The Herald | HeraldOnline.com

Aerocrine: Positive reimbursement coverage continues for Aerocrine's asthma test
The Herald | HeraldOnline.com
Specifically, FeNO testing is covered for the treatment of asthma when it is used in the diagnosis of allergic airway inflammation or when used in determining likelihood of steroid responsiveness in individuals with chronic symptoms suggestive of

View full post on asthma – Google News

BSX’s Alair Receives Reimbursement – Zacks.com

BSX's Alair Receives Reimbursement
Zacks.com
Data from the Research in Severe Asthma (“RISA”) trial found that patients with severe refractory asthma, when treated with Alair BT system, experienced stability in lung function without clinical complications over a five-year period.
St. Luke's Episcopal Hospital Offers Bronchial Thermoplasty Treating Severe MarketWatch (press release)
CMS acknowledges clinical improvement linked with use of Alair Bronchial News-Medical.net
Boston Scientific's Alair thermoplasty system wins CMS approvalZenopa

all 10 news articles »

View full post on asthma – Google News